Becton Dickinson (BDX) Other Operating Expenses (2009 - 2026)
Becton Dickinson's (BDX) quarterly Other Operating Expenses came in at -$66.0 million in Q1 2026, down 88.57% year-on-year from -$577.5 million in Q1 2025, and down 32.0% on a QoQ basis from -$50.0 million in Q4 2025.
Becton Dickinson (BDX) Other Operating Expenses (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Other Operating Expenses data on file, last reported at -$66.0 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 88.57% year-over-year to -$66.0 million in Q1 2026; TTM through Mar 2026 was -$439.0 million, a 47.81% decrease from a year earlier, with the FY2025 full-year figure at -$396.0 million, down 78.38% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$66.0 million, down from -$50.0 million in the prior quarter.
- Over the last five years, Other Operating Expenses for BDX reached as high as $203.0 million in Q3 2023 and fell as low as -$285.0 million in Q3 2025.
- Historically, Other Operating Expenses has averaged -$34.8 million across 5 years, with a median of -$29.0 million in 2022.
- Across the five-year window, Other Operating Expenses soared 776.67% in 2023 and slumped 853.85% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at -$3.0 million in 2022, then plunged by 266.67% to -$11.0 million in 2023, then tumbled by 154.55% to -$28.0 million in 2024, then plunged by 78.57% to -$50.0 million in 2025, then slumped by 32.0% to -$66.0 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$66.0 million in Q1 2026, -$50.0 million in Q4 2025, and -$285.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.00 Mn |
| Dec 31, 2025 | -50.00 Mn |
| Sep 30, 2025 | -285.00 Mn |
| Jun 30, 2025 | -38.00 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Dec 31, 2024 | -28.00 Mn |
| Sep 30, 2024 | -136.00 Mn |
| Jun 30, 2024 | -98.00 Mn |
| Mar 31, 2024 | 23.00 Mn |
| Dec 31, 2023 | -11.00 Mn |
| Sep 30, 2023 | 203.00 Mn |
| Jun 30, 2023 | 13.00 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -30.00 Mn |
| Jun 30, 2022 | -11.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 88.00 Mn |
| Mar 31, 2021 | -296.00 Mn |